| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | HemoGenyx New treatment for blood diseases, such as leukemia and lymphoma. | 0 | 0 | 0 | N/A |
 | Science Creates Science Creates is a biotechnology research company that specializes in biotech, chemistry, quantum technologies. | 0 | 0 | 0 | N/A |
 |  ErVimmune Targeting shared unconventional tumor antigens in cancer immunotherapy R&D oncology | 1 | 1 | 0 | 17 |
 | ACS Biotech [Automatic translation follows] The cartilage repair solution ACS Biotech Develops Innovative, Reliable, Durable Injectable Cartilage Repair Solution to Treat Cartilage Injuries Type: | 13 | 5 | 7 | 7 |
 | Quantificare QuantifiCare is a fast growing leading Imaging CRO offering: - Pre-clinical to phase IV clinical trial services across a wide range of clinical areas to pharmaceutical, biotech and cosmetic industries. - Innovative imaging tools tailored for medical specialists including plastic surgeons, aesthetic specialists and dermatologists. Type: | 1 | 1 | 0 | 137 |
 | Inlightened Bridging the knowledge gap between the boldest innovators and brightest HCPs with diversity, transparency, and quality Inlightened’s tech-enabled platform connects client companies to a vetted network of healthcare professionals providing on-demand consultation and expertise. Its SaaS marketplace bridges the knowledge gap between the sector’s brightest minds and boldest innovators, with non-patient-facing gig work, and an unprecedented focus on diversity, quality, and transparency. Inlightened was acquired by LocumTenens.com, a member of the Jackson Healthcare family of companies, in August 2023. healthcare, health tech, biotech, consulting, due diligence, innovation, product development, expert knowledge, medical advisory, clinical consulting, market research, healthcare advisors, executive … Type: | 1 | 0 | 1 | 32 |
 | Ocean Diagnostics Inc. Diagnosing and protecting the health of our own oceans and waterways from microplastic pollution and biodiversity loss. Ocean Diagnostics is an environmental impact company that develops innovative technology to empower researchers and community scientists to collect and analyze the microplastics and environmental DNA data needed to inform decision making. Together, we help to protect our planet from plastic pollution and biodiversity loss. microplastics, environmental DNA (eDNA), Marine pollution, and community science and education Type: | 0 | 0 | 0 | 14 |
 | ANGANY Immunity Humanité ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur. allergenes recombinants, immunotherapy, … Type: | 0 | 0 | 0 | 18 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 0 | 0 | 10 |
 | First Wave BioPharma, Inc. Targeted, Non-Systemic Therapies for Gastrointestinal Diseases First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. First Wave’s niclosamide portfolio is led by three clinical programs: FW-COV, for COVID-19 gastrointestinal infections; FW-UP, for ulcerative proctitis … Type: | 1 | 0 | 1 | 12 |
 | Neurolixis New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Rett Syndrome, Parkinson's disease, Biased agonism, and Orphan Drug Type: | 2 | 1 | 1 | 7 |
 | Precision BioSciences, Inc. Dedicated to Improving Life. Precision BioSciences, Inc. (Nasdaq: DTIL) is a pre-clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com. Gene Editing and Gene Therapy Type: | 2 | 1 | 1 | 124 |
 | Green City Solutions GmbH We grow fresh air! #CityTree #CityBreeze #WallBreeze 🍃 We grow fresh air - with moss, naturally. More than half of humanity lives in cities – and the trend is rising. Cities are clearly the living space of the future. And yet our most important resource, the air we breathe, is in many places so polluted that breathing is harming our health. In the future we have in mind, fresh air in urban areas is available to everyone. That’s why we developed the world’s first regenerative bio-tech filters for verifiable improvements in air quality. #WeGrowFreshAir with CityTree, CityBreeze and WallBreeze. Moos, … Type: | 35 | 4 | 29 | 34 |
 | Nanoscribe Make small things matter. In 2007, a team of researchers from Karlsruhe Institute of Technology (KIT) set out to rethink microfabrication. At that time, Two-Photon Polymerization (2PP), the underlying core physics and chemistry for the Nanoscribe technology, was a small niche research topic. The founders however recognized the potential and made 2PP-based 3D printers commercially available. Besides the 2PP-based 3D Microfabrication technology, Nanoscribe revealed its proprietary Two-Photon Grayscale Lithography (2GL ®) with presenting the maskless lithography platform Quantum X in 2019. 2GL combines 2PP with the qualities of grayscale lithography and thus enables rapid and precise microfabrication of ultra-smooth surfaces … Type: | 4 | 0 | 2 | 74 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 0 | 0 | 0 | 10 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 0 | 0 | 0 | 16 |
 | Life Supporting Technologies Innovation comming to life Life Supporting Technologies (LifeSTech) is a research, development and innovation group, located within the Universidad Politecnica de Madrid (UPM) and dedicated to design, development and evaluation of services and applications based on ICT, to create and promote new ideas, methods and technological solutions to improve people's lives. e-Learning, e-Inclusion, and e-Government | 1 | 1 | 0 | 28 |
 |  NeoNeuro APTAMARKERS: Diagnostic fingerprints in blood for pathology detection NeoNeuro has developed a new scientific approach named Aptamarkers. In the past, biomarkers for the diagnosis of diseases have been developed based on an understanding of the disease and the effect of the disease on the regulation of proteins or metabolites. This approach is time-consuming and expensive as experimental hypothesis regarding the pathophysiology of the disease must be tested and progressively built upon. NeoNeuro set out to develop a new platform with the capacity to screen all epitopes that are present in blood. We are not only screening all molecules in blood … Type: | 1 | 1 | 0 | 2 |
 | Veracyte, Inc. High-value insights, high-impact decisions Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. | 4 | 3 | 1 | 561 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 1 | 0 | 1 | 25 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 1 | 1 | 329 |
 | BioVersys AG Leadership in overcoming the antibiotic resistance crisis. BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company’s award-winning TRIC technology we can overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria, towards the identification of new treatment options in the antimicrobial and microbiome fields. By this means, BioVersys addresses the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. Our … | 1 | 0 | 1 | 24 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 1 | 0 | 49 |
 | MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company A Swiss Microbiota biotherapeutics and Vaccines company, a spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona. The patent protected Apy platform is a unique mechanism to generate protective immune response against enteric infections and to shape the intestinal microbiota in medical conditions with two applications: 1. ApyraVax® with the lead indication of Clostridium difficile infection 2. ApyraMed® with lead indications as enhancer in cancer immunotherapy and modulator of antibiotic-induced disbyosis. Research experiments and preclinical trials are performed in the research lab hosted at IRB. The company is looking for seed funding … Type: | 1 | 1 | 0 | 1 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 1 | 0 | 10 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 0 | 0 | 0 | 23 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 0 | 0 | 0 | 15 |
 | Lawford Davies & Co Life Sciences Lawyers in the UK and Germany We are a niche life sciences law firm with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: | 0 | 0 | 0 | 5 |
 | Crafting Future Wir produzieren nachhaltige Mehrwegbehälter und entwickeln gemeinsam die für dich passende Mehrweglösung Disposable waste is one of the biggest problems of our time. At the same time we know that there will never be a world without plastics. That is why we have made it our mission to question the plastics industry. In our material selection, product design and product development, we place a special focus on the end of a product's life cycle. In doing so, we consider the recovery of an equivalent amount of plastic compared to the amount used in manufacturing. We develop our own reusable products … Type: | 3 | 0 | 3 | 20 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 0 | 0 | 0 | 10 |
 | Oculyze One of the leading platforms for cloud based quantitative image recognition. Using machine learning and Artificial Intelligence Oculyze has transferred the computer vision software for lab equipment from the table top to the cloud. To prove this revolutionary approach works and is market ready, Oculyze launched the yeast cell counters for breweries and wineries. This device works using a microscope connected to a smartphone and the Oculyze app to upload the images to the cloud where they are analysed by image recognition algorithms. These combine methodical pattern recognition with artificial intelligence and deep learning to offer quantitative real-time image analysis. … Type: | 1 | 1 | 0 | 7 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 0 | 0 | 0 | 77 |
 | Quantgene We are on a mission to KILL CANCER with Intelligent Genomics. Quantgene is on a mission to detect and end cancer early with Intelligent Genomics. By making genomics intelligent, we can now detect and eliminate cancer at the earliest stages. Universal early detection of cancer can reduce mortality rates up to 80% and end cancer as we know it. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection Type: | 3 | 0 | 3 | 43 |
 | Gaskiya Diagnostics Rapid, low-cost, easy-to-use diagnostic tests for aquaculture. We develop ultra-low cost, paper-based rapid diagnostic test kits with equipment-free results. | 0 | 0 | 0 | 4 |
 | Starlab We believe in progress through science. Our solutions enable bright minds to change the world. We believe in progress through science. Our solutions enable bright minds to change the world. We are “Passionate for Science”. Since 1998. Our product portfolio specializes in the field of Liquid Handling Technology and laboratory products. Our product portfolio includes laboratory consumables such as pipette tips, single and multi-channel pipettes, cell culture, tubes, PCR consumables, nitrile and latex gloves, and benchtop equipment for general laboratory use. Our products and services are in daily use at research institutions in biological and medical institutes, universities and hospitals, … Type: | 1 | 1 | 0 | 280 |
 | EuroGalenus Executive Search Consultants Executive Search & Talent Assessment in: Industry, Service companies, Life Sciences, Digital Health, and other sectors. EuroGalenus is an International independent executive search and leadership consulting firm founded in 1992 and member of the ECI Group. Our searches are focused on the board and senior executive level of the organizations and we have a track record in fields such as Industry, Services companies, Health and Biosciences, Consultancy and Professional Services, etc. Most of our work is pan-european and we have an outstanding track record in international searches. Since 1994 EuroGalenus is also a member of the Association of Executive Search … | 4 | 1 | 2 | 3 |
 | Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. Type: | 2 | 2 | 0 | 2 |
 |  CellSine Discover your favorite frequencies to boost your drug discovery business CellSine provides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher. It delivers a platform tool for a that enables a wide variety of biochemical studies. Biotechnology, Cell culture monitoring, Proteïn - Proteïn interactions, Suspension cultures, Receptor signaling, Biofilm maturation, and T lymphocyte activation Type: | 1 | 1 | 0 | 4 |
 | mindtrace | 2 | 0 | 1 | N/A |
 | Tetratherix Tetratherix has developed the first biostealth fluid matrix to disrupt regenerative medicine and targeted mRNA delivery. Tetratherix has developed a proprietary fluid matrix that is invisible to the body & does not induce any foreign body reaction to evolve regenerative medicine and targeted therapeutic delivery. Tetramatrix is a water based polymer solution that forms an adhesive hydrogel once administered to the body. The product is fully synthetic, biocompatible and resorbable. After a decade of development with meticulous polymer programing, Tetratherix is advancing the world of biopolymers by developing real world applications specific to multiple indications in an effort to change … Type: | 0 | 0 | 0 | 10 |
 | Precision Medicine Scotland Innovation Centre We bring together innovators, clinicians and researchers to facilitate the adoption of Precision Medicine in Scotland. Welcome to Precision Medicine Scotland’s home on LinkedIn. Follow us for updates on collaboration opportunities, funding news and the latest updates on Scotland’s advances in Precision Medicine. Precision Medicine Scotland Innovation Centre (PMS-IC) enables the development of new products and services for a global market. PMS-IC is an Innovation Centre that brings together industry innovators, clinicians and world-class researchers to collaborate on precision medicine opportunities. Our focus is on linking Scotland’s domain expertise, data assets and world-class delivery infrastructure to accelerate the adoption of … Type: | 3 | 0 | 3 | 7 |
 | Integrated Micro-Chromatography Systems A leader in recombinant enzymes and automated micro-chromatography technologies About Integrated Micro-Chromatography Systems, Inc. At Integrated Micro-Chromatography Systems (IMCS), we strive to address the growing needs of clinical and research laboratories through advanced technologies that increase testing efficiency. IMCS products help to drive the future of precision medicine. We understand the importance of accuracy, which is why we are committed to delivering products that consistently provide fast, reliable results. Company History Integrated Micro-Chromatography Systems, Inc (IMCS) was founded in January 2013 by three scientists from the University of South Carolina. IMCS designs, develops, manufactures, and distributes next-generation recombinant proteins and … Type: | 1 | 0 | 1 | 29 |
 | Ossium Health The Greatest Wealth is Health Building a Healthier Future Our mission is to improve the health, vitality, and longevity of human beings through bioengineering. Who We Are At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good. PRINCIPLES The values we live by Impact We are mission-driven and results-oriented. We believe that a healthier world is a better one … Type: | 2 | 0 | 2 | 101 |
 | Cyclica (acquired by Recursion, Nasdaq: RXRX) From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics Type: | 15 | 2 | 11 | 8 |
 | PDC*line Pharma A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) Founded in 2014 as a spin-off of the French Blood Bank (EFS), PDC*line Pharma is a French-Belgian biotech company that develops an innovative class of active immunotherapies to treat cancers. This cancer vaccine contains proprietary, potent, and scalable plasmacytoid dendritic cell line (PDC*line), whose remarkable characteristics make them excellently suited for immunotherapy. PDC*line is much more potent to prime and boost antitumor antigen, including neoantigens, specific cytotoxic T-cells than conventional vaccines and improves the response to checkpoint inhibitors. PDC*line offers unique advantages: - PDC*line … Type: | 9 | 1 | 4 | 37 |
 |  BioNTech SE Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing … Type: | 38 | 17 | 8 | 4,420 |
 | Creativ-Ceutical Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other … Type: | 0 | 0 | 0 | 83 |
 | Venn Life Sciences - part of hVIVO plc Integrated Drug Development from Discovery to Market - Part of the hVIVO plc Venn Life Sciences - part of hVIVO plc is an Integrated Drug Development partner offering an unique combination of drug development consultancy, clinical trial design and execution, enabling us to create, plan and execute drug development programmes effectively for our customers. Venn’s capabilities and expertise includes: CMC, Non-Clinical, Clinical Development and Regulatory Affairs. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. Visit our website - www.vennlifesciences.com for more information. Drug Substance … Type: | 3 | 1 | 1 | 110 |
 | IDbyDNA Precise Insights for Better Health Delivering on our promise to identify any microbe, from any sample, anywhere in the world will take a team of dedicated, passionate, and experienced individuals. The members of our team at IDbyDNA have a strong track record of building successful organizations and bring a breadth of multi-disciplinary experience including; microbial genomics, bioinformatics, software engineering, laboratory medicine, and commercialization. In concert with the global community of researchers, clinicians, industry partners and policy makers, we will revolutionize microbial detection and bring new solutions to solve problems that are not currently addressable with today’s technologies. Type: | 3 | 0 | 3 | 27 |
 | Roka Furadada Smart active ingredients, safer sun exposure Catalonia Exponential Leader 2023 Roka Furadada’s mission is to reduce the incidence of skin cancer through research, development and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact OUR PURPOSE Roka Furadada wants to help to prevent and reduce the incidence of skin cancer. HOW ARE WE GOING TO DO IT? Developing the first intelligent ultra violet radiation filter: SMART UV, with new molecules that entail therapeutic activity to prevent and treat diseases associated with sun exposure. Cosmetics, Raw Materials , Ingredients, Cosmetic Ingredients, Sunscreen, Sun protection … Type: | 5 | 1 | 5 | 28 |
 | Five Alarm Bio Limited Boosting the body's ability to defend against the damage of aging Five Alarm Bio is a drug discovery company based in Cambridge, UK focusing on novel approaches to anti-aging, with broad potential therapeutic application. We are researching therapeutics that boost the body's ability to defend against the damage of aging. Type: | 0 | 0 | 0 | 4 |
 | Dualyx Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need. | 0 | 0 | 0 | 17 |
 | Floating Genes Early cancer diagnosis in liquid biopsy by ultra-sensitive ctDNA sequencing. Early cancer detection from liquid biopsies | 7 | 6 | 1 | 4 |
 | CircaGene CircaGene platform for personal genetic tests World's first Patented Incognito DNA Encryption with actionable result The mission of CircaGene is to provide world-class BioInformatics Services to protect and improve Public Health both at population and individual levels. Bioinformatics, Sequencing, Genomic, Genetic Data Privacy, Actionable Genomics, Genetic Coach, Optimised Lifestyle, Science in your side, DNApower, and Genetic Heroe Type: | 0 | 0 | 0 | 7 |
 | RHNANOPHARMA RH/Nanopharma is a Biopharma company dedicated to treating, preventing, slowing and reversing inflammatory diseases. | 0 | 0 | 0 | N/A |
 | NanoSpun Technologies We harness the power of biology to create revolutionary live-active cell-based products and solutions. NanoSpun is a global pioneer and frontrunner in the biotech, advanced materials and bioprinting spaces. We are leading the way to a whole new generation of cell-based products and solutions through the intelligent application of NanoSpun biological fabrics. No other company can do what we do. We encapsulate live and active biological cells and organisms, including bacteria, yeast, algae, plant cells, and mammalian to produce living tissues and fabrics with a wide application across many industries. Our current market focus is to revolutionize Skincare and Bioprocessing. … Type: | 0 | 0 | 0 | 10 |
 | Vytrus Biotech Natural Innovation for a Better Life. Applying the real power of plants to cosmetics through biotechnology We create natural active ingredients for skincare and haircare through innovative and sustainable biotechnology processes which obtain the real power of plants. Totipotent Cells Type: | 0 | 0 | 0 | 35 |
 | Limula Cell & Gene Therapy: Automated. Scalable. Accessible Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics. Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T Type: | 1 | 1 | 0 | 17 |
 | Innixim Type: | 0 | 0 | 0 | 1 |
 | Nutrazur [Automatic translation follows] Powdered essential oils!! Concept invented and patented by Bruno OBRIOT and for secure therapeutic purposes Bruno OBRIOT Homeopath and aromatherapist practiced privately for 14 years. He invented and patented the process of transforming essential oils into powder using oyster shell powder. Its objective is to make it safe to take these essential oils orally with a dosage form making this possible. The powder being put into capsules. His experience in the office and his numerous prescriptions for preparations made in pharmacies have allowed him to refine the most effective synergies. Type: | 2 | 0 | 2 | N/A |
 | Vaxinano Innovation for Human and Animal Health Protection Vaxinano: a new-generation vaccine platform. Vaxinano is a biotechnology company based near Lille, specialising in the development of prophylactic and therapeutic vaccines to combat infectious diseases in animal and human health. We offer a vaccine platform from which innovative non-adjuvanted vaccines are developed. This platform not only makes it possible to develop new vaccines and improve existing vaccines (by replacing adjuvants), but also to reduce or even replace the use of antibiotics. The patented technology is based on biosourced nanoparticles (starch and lipids) manufactured according to the principles of green chemistry and Good … Type: | 5 | 2 | 4 | 14 |
 | Evexta Bio Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in … Type: | 4 | 0 | 4 | 14 |
 | GenSearch Talents for the Life Sciences Assessment | Coaching | Executive Search At GenSearch, we are dedicated to empowering organisations and executives in the Life Sciences sector by providing top-tier Executive Search, Assessment, and Coaching services. Our clients and the executives we support respect us for our deep expertise in complex environments, reliable processes, strong ethics, and our openness to share knowledge and connections. #Assessment #coaching #Coaching #mapping #lifescience #executive search Executive Search, Evaluation, Head Hunting, Biotechnology Industry, Development Center, Recruitment, Life Sciences, Healthcare, Assesment, Diagnostic, Coaching, Assessement, Retained executive search, Medical Devices, Pharmaceuticals, Talent Strategy, Top Management, Recruitment, Startups, coaching, … Type: | 4 | 0 | 4 | 14 |
 | LimFlow SA Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI) LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations … Type: | 1 | 1 | 0 | 39 |
 | Vetbiobank Leading Animal Cell Therapy - Improving Animal Healthcare. Vetbiobank is a biotech company specialized in veterinary regenerative medicine. For our customers and their animal companions (dogs, cats, horses), we are leveraging the unique biological potential of neonatal stem cells. Those stem cells deliver locally an appropriate set of bioactive messages to organise and promote the harmonious healing of injuries or dampen inflammatory chronic diseases. Funded in 2011, Vetbiobank has built its expertise on the experience of its founder, former expert in human cell therapy development, and cord blood derived stem cells. The mission of Vetbiobank is to provide veterinarians with … Type: | 1 | 1 | 0 | 10 |
 | Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: | 1 | 1 | 0 | 117 |
 | Omind Neurotechnologies Unleash human capabilities of your organisation, leveraging the power of AI and neurosciences 🧠 Discover Omind Neurotechnologies, your HR co-pilot that unleashes human potential at work using neuroscience and AI! Omind's innovative solutions provide a better understanding of people's behavior (emotional management, decision-making, adaptation...) in order to train them using games and scientific data measurements. Backed by 7 years of R&D in neuroscience with major partners such as IRBA (French Army), CNRS, AP-HP, Omind provides more experiential, impactful and personalized training in a complex, fast-changing world. Our team includes 20+ passionate people, including 8 PhD in data science, neurosciences, IT, … Type: | 14 | 4 | 10 | 28 |
 | Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … Type: | 2 | 1 | 2 | 11 |
 | MagIA diagnostics Your immunoassay: Faster, Simpler, Accessible MagIA is developing a multi-analyis "Point-of-Care" that can be used outside of any clinical environment. With a first focus on infectious diseases MagIA is providing a syndromic testing approach at the Point of Care outside of traditional clinical environment. With the motto “a better screening for a better care", MagIA focuses first on the rapid detection of infectious diseases, starting with an HIV-Viral Hepatitis combo, to link to care Key « high-risk » populations. MagIA's innovation is a one-step no-wash immunoassay method which brings unique characteristics: (1) laboratory quality on a portable device, usable indoor, … | 8 | 6 | 4 | 17 |
 | Osmoz Lab [Automatic translation follows] The first range of food supplements compatible with chemotherapy treatments. Osmoz Lab has created the very first range of food supplements compatible with chemotherapy treatments. Developed by a Doctor of Pharmacy, the Osmoz range reduces the unwanted effects of chemotherapy in a natural and interaction-free way. 🌱 100% natural origin 🔬 Formulation based on clinical study results ⚗️ Based on dry plant extracts for optimal effectiveness 💊 Plant-based capsule 🇫🇷 Made in France Type: | 3 | 3 | 0 | 2 |
 | AgroLab BioMed [Automatic translation follows] Innovating for sustainable agriculture LivingLab AgroLab Biomed website Type: | 2 | 1 | 2 | N/A |
 | SmartCatch For a reliable liquid biopsy accessible to everyone Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was … Type: | 15 | 5 | 12 | 21 |
 | CrocosGoDigital [Automatic translation follows] AI for cognitive stimulations for kids by coding robots/drones/..., and brain dysfunctions detection. CrocosGoDigital is a start-up specializing in Neuro-Education for children aged 6-12 and seniors – use of neuroscience and AI for a new generation of training in the Programming of robots, drones, AI engines, etc. The objective is to boost/stimulate the cognitive functions of children and seniors, whatever their level, precocious or experiencing academic difficulties, to help them progress at their own pace through motivation. This is why our training is 'adaptive' and designed to stimulate cognitive functions. Ultimately, with our partners in Neuroscience and … Type: | 18 | 6 | 2 | 17 |
 | Antofénol [Automatic translation follows] Our vision: Obtain the best from the plant, without using conventional chemical solvents. Our expertise: - Simultaneously exploit 4 proven eco-extraction technologies. - Provide solutions for the development of your ingredients in order to enrich your range of active biomolecules (polyphenols, flavonoids, alkaloids) Our objective: To offer eco-responsible solutions to enable you to respond to future ecological and economic challenges. vacuum distillation, Vegetable eco-extraction, R&D, objectified ingredients, microwave, Ultrasound, Atomization, Lyophilization, Grinding, Natural extracts, Active ingredient, 100% natural active ingredients, eco responsible, polyphenols, essential oils, cosmetics, perfumery, nutraceuticals, and agro-food Type: | 8 | 3 | 6 | 18 |
 | Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 31 | 10 | 21 | 43 |
 | LYSOGENE Improve the lives of children with CNS diseases Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early … Type: | 7 | 5 | 0 | 10 |
 | Penrhos Bio A Joint Venture with Unilever PLC, creating a world free of harmful Biofilms though novel technology inspired by Nature. Were are a Joint Venture initiative with Unilever PLC formed in late 2019 with exclusive rights to the commercialise a new and novel technology based on furanone chemistry that inhibits Biofilms. Inspired by the biology of red seaweed, this single molecule platform offers a sustainable low-toxicity alternative to existing biocides. It has activity against bacteria by blocking quorum sensing and communication through multiple identified molecular targets in the bacteria, but is also effective against moulds and algae making this a unique … Type: | 0 | 0 | 0 | 7 |
 | Causeway Therapeutics Healthy Ageing Through Musculoskeletal Health Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in … Type: | 2 | 0 | 1 | 7 |
 | Deep Lens Accelerating clinical trial matching in oncology Deep Lens is a digital healthcare company focused on enabling faster recruitment of the best-suited cancer patients for clinical trials at the time of diagnosis using VIPER. Deep Lens’ AI-driven cloud platform gives care teams, trial coordinators and oncologists visibility into all available trials and the ability to collaborate on groundbreaking cancer research across all cancer types. Artificial Intelligence, Pharmaceuticals , Cancer Research, Oncology, and Pathology Type: | 4 | 1 | 3 | 5 |
 | Olaris, Inc Removing the Guesswork from Medicine Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARISTM diagnostics products, which aim to optimize treatments and outcomes for individual patients. Metabolite diagnostics empower therapeutic selection, treatment effectiveness monitoring, disease diagnosis, and target identification across indications and therapeutics areas, including oncology, solid-organ transplant, and neurodegeneration. Our mission is to remove the guesswork from medicine. Diagnostics, Machine Learning, Metabolomics, NMR, Mass Spectrometry, Statistics, Transplant, and Oncology Type: | 1 | 1 | 1 | 14 |
 | HP Health Solutions Germany GmbH For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 0 | 0 | 0 | 23 |
 | AccuHealth Chile [Automatic translation follows] Together in control of your health We are the first Telehealth company in Chile and South America. Our Virtual Clinical Hospital is dedicated to providing continuity of care and remote care, with emphasis on prevention and close monitoring of patients through our Telemonitoring service, who are accompanied and guided, 24 hours a day, by a team of highly trained professionals in their work areas. Our business model adapts to the specific needs of each institution, becoming an ally and strategic complement for doctors, insurers and health providers, delivering an innovative service with high added value and focused … Type: | 0 | 0 | 0 | 14 |
 | LONO Côte d'Ivoire Transformez vos sous-produits en revenus supplémentaires LONO is a biotechnology company in Côte d'Ivoire, converting organic waste into electricity and fertilizer. Agriculture, Biotechnology, and Sustainability Type: | 2 | 1 | 2 | 13 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 33 | 12 | 25 | 66 |
 | PB&B Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, … Type: | 0 | 0 | 0 | 4 |
 | Versantis Multiorgan support for rare pediatric and acute liver diseases Versantis is a clinical-stage pharmaceutical company developing a new generation of orphan medicines to revolutionize the care of patients with liver and rare pediatric diseases. We address the unmet medical needs in emergency care. Our mission is to support acute decompensations of cirrhosis and to save infants born with rare genetic disorders. Hepatology, Hyperammonemia, Metabolic disease, Liver diseases, and Gastroenterology | 0 | 0 | 0 | 2 |
 | SOPHiA GENETICS Democratizing Data-Driven Medicine, Together! SOPHiA GENETICS is the creator of SOPHiA DDMTM, a cloud-based platform capable of analyzing data and generating insights from complex multimodal data sets and different modalities. The SOPHiA DDMTM Platform enables healthcare institutions to get quick, robust insights from their data. We apply our technology to areas such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support research and drug development efforts. SOPHiA GENETICS' data-sharing methodology also helps researchers and healthcare professionals work together as a community by sharing and leveraging patterns identified via artificial intelligence and machine learning. Our … Type: | 23 | 10 | 11 | 488 |
 | SwissDeCode Real-time food quality, authentication and compliance for farmers, food manufacturers and food authorities. SwissDeCode helps farmers and food manufacturers to grow and produce food that is safe to eat by offering a variety of rapid, on-site DNA detection solutions. We have been able to help companies in different parts of the food supply chain to detect food contamination and adulteration earlier, avoid food recalls and improve the trust of customers in their products. Get in touch to discuss your testing needs. Food Authentication, Supply Chain Traceability, DNA Testing, Sustainable Operations, Food Safety, Food Compliance, Right First Time, Undeclared ingredients, Salmonella, … Type: | 7 | 3 | 4 | 11 |
 | Molecule AG A decentralised biotech protocol porting intellectual property into web3 and launching biotech DAOs We propel science from lab to life, fueled by a community committed to human progress. blockchain, pharma, health, science, biotech, and Token Bonding Curves Type: | 5 | 0 | 2 | 31 |
 | VectivBio AG Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and … Type: | 2 | 0 | 1 | 57 |
 | Livinguard Livinguard’s patented hygiene technology platform uniquely turns any textile into a permanent self-disinfectant. xxxxxxxx Type: | 3 | 0 | 2 | 37 |
 | Valence Labs Redefining scientific discovery to radically improve lives Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery. Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) in May 2023, Valence Labs continues as a semi-autonomous AI research engine within Recursion aiming to advance the frontier of deep learning in drug discovery. Valence Labs operates with the unique combination of the intellectual freedom of academia but the resources and stability of industry. Valence Labs is headquartered in … Type: | 9 | 1 | 7 | 35 |
 | TRIANNI, Inc an AbCellera Company Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses … Type: | 0 | 0 | 0 | 1 |
 | Skye Bioscience Inc. Unlocking the pharmaceutical potential of cannabinoids Skye Bioscience (OTC:SKYE) is focused on unlocking the pharmaceutical potential of the endocannabinoid system, initially through modulation of the CB1 receptor, to treat diseases with inflammatory, fibrotic, and metabolic processes. Type: | 2 | 1 | 1 | 13 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: | 15 | 4 | 8 | 10 |
 | D4H - Data for Health Data for Health We reduce the uncertainty of health professionals and their patients based on the evidence the data provide. Machine Learning, Data Science, Bioinformatics, and DeepLearning Type: | 5 | 0 | 5 | 0 |
 | Biodexa Pharmaceuticals PLC Advancing Medicines for a Brighter Future Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain. The Company’s lead candidate, MTX110, is being studied in aggressive rare/orphan brain cancer indications including recurrent glioblastoma and diffuse midline glioma. MTX110 is a solubilised formulation of the histone deacetylase (HDAC) inhibitor, panobinostat. This proprietary formulation enables delivery of the product via convection-enhanced delivery (CED) at potentially chemotherapeutic doses directly to the site of the tumour, by-passing the blood-brain barrier and avoiding systemic toxicity. | 0 | 0 | 0 | 23 |
 | GENESIS Biomed Helping health & biotech entrepreneurs making their dream come true. GENESIS Biomed is a consulting company formed by entrepreneurs and with vocation of service to entrepreneurs and research centers. In GENESIS Biomed we offer consulting services, we invest in projects in seed stage and we develop our own R+D projects. Our sectors are biopharmaceutical, biotechnological, medical devices, in vitro diagnostic, foodtech, nutraceutical and cosmetic. We are born in May 2017 and we are located in the Barcelona Science Park. Entrepreneurship, Consultancy, Research, Innovation, Business plan, Fundraising, Interim CEO, Tech transfer, Strategic plan, Regulatory affairs, Business Development, Biotechnology, Medical devices, Diagnostic, … Type: | 1 | 0 | 1 | 17 |
 | Galmed Pharmaceuticals Ltd. A clinical-stage drug development biopharmaceutical company for liver, metabolic & inflammatory diseases Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, AramcholTM, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide. Our corporate headquarters is located in Tel Aviv, Israel. For more information about Galmed, please visit our website at: www.galmedpharma.com Type: | 1 | 1 | 0 | 11 |
 | Arete Medical Technologies Our mission is to improve patient outcomes and healthcare efficiency, starting with chronic respiratory conditions. Chronic respiratory diseases reduce the quality of life of millions worldwide, and are a major cause of death. Health systems are increasingly strained. We believe improved care in the future can only come from more preventative and precision care. We apply advances in digital technologies and medical devices to both improve care and health system efficiency. Type: | 5 | 1 | 3 | 4 |
Startup